Praxis Precision Medicines
17
6
7
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.8%
2 terminated/withdrawn out of 17 trials
71.4%
-15.1% vs industry average
29%
5 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Role: lead
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)
Role: lead
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Role: lead
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Role: lead
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Role: lead
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)
Role: lead
A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Role: lead
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Role: lead
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Role: lead
A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628
Role: lead
A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor
Role: lead
A Clinical Trial of PRAX-944 in Participants With Essential Tremor
Role: lead
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
Role: lead
A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
Role: lead
A Clinical Trial of PRAX-114 in Participants With Essential Tremor
Role: lead
A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder
Role: lead
A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder
Role: lead
All 17 trials loaded